Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model

PurposeThe aim of this study was to evaluate changes in body weight, liver weight, blood glucose, liver injury markers, pro-inflammatory factors and oxidative stress marker levels in obese mice with HFD induced NAFLD after semaglutide use.Patients and methodsThe 24 C57BL6J mice were randomly divided...

Full description

Bibliographic Details
Main Authors: Shu Niu, Shuchun Chen, Xing Chen, Qingjuan Ren, Lin Yue, Xiaoyu Pan, Huiying Zhao, Zelin Li, Xiaoyi Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Endocrinology
Subjects:
semaglutide
hepatic
NAFLD
hepatic fibrosis
metabolomics
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1046130/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.1046130/full

Similar Items